Monovisc® , is a sterile preparation supplied in a disposable glass syringe delivering 4.0 mL. Each mL of Monovisc®
, contains 22 mg/mL of crosslinked hyaluronic acid (HA) as well as inactive ingredients.
Monovisc®, is a single, intra-articular injection into the synovial cavity of a human joint to relieve the symptoms of
Monovisc® , is indicated as a viscoelastic supplement or a replacement for synovial fluid in human joints. Monovisc®
, is well suited for long term relief of the symptoms of human joint dysfunctions such as osteoarthritis. The actions of
Monovisc® are long term relief of symptoms by lubrication and mechanical support.
STORAGE AND HANDLING:
Store at 2 to 25°C.